Safety and Preliminary Efficacy of SNK01 in Combination With Trastuzumab or Cetuximab in Subjects With Advanced HER2 or EGFR Cancers
NKGen Biotech, Inc.
NKGen Biotech, Inc.
Maimonides Medical Center
University of Kansas Medical Center
Mayo Clinic
M.D. Anderson Cancer Center